{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-25-000198","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.532730+00:00","generated_at":"2026-05-17T17:08:56.536955+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Globus Medical Q2 net sales $745.3M (+18.4%); GAAP EPS $1.49, non-GAAP $0.86","bullets":["Net sales $745.3M, up 18.4% YoY (17.6% constant currency); US Spine grew 5.7% as-reported.","GAAP net income $202.8M ($1.49 diluted EPS) vs $31.7M ($0.23) a year ago; includes $110.6M bargain purchase gain.","Non-GAAP diluted EPS $0.86 vs $0.75 (+14.1%); record quarterly non-GAAP EPS.","Full-year 2025 guidance reaffirmed: revenue $2.80-2.90B; non-GAAP EPS $3.00-3.30.","Closed Nevro acquisition; net cash from ops $77.9M, non-GAAP free cash flow $31.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-25-000198","json":"https://secwatch.observer/filing/0001562762-25-000198.json","markdown":"https://secwatch.observer/filing/0001562762-25-000198.md","text":"https://secwatch.observer/filing/0001562762-25-000198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000198/0001562762-25-000198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276225000198/gmed-20250807x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:08:56.536955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}